Table 3 Measurements of 68Ga-NODAGA-RGD or 18F-FDG uptake in confirmed positive uptake
68 Ga-NODAGA-RGD | 18F-FDG | |||||||
|---|---|---|---|---|---|---|---|---|
All | Median SUVmax (g/mL) | Median Tumor-to blood pool background ratio | Median MTV 60% (cm3) | Confirmed Lesions (N) | Median SUVmax (g/mL) | Median Tumor-to blood pool background ratio | Median MTV 60% (cm3) | Confirmed Lesions (N) |
Primary sites | 3.85 | 4.58 | 5.21 | 9 | 12.1 | 5.94 | 2.31 | 9 |
Involved lymph nodes | ||||||||
Neck and supraclavicular | NA | NA | NA | NA | 4.3 | 2.39 | 1.03 | 1 |
Mediastinum | 3.2 | 1.93 | 1.07 | 5 | 3.75 | 1.99 | 0.73 | 14 |
Abdomen-Pelvis | 2.33 | 1.94 | 1.88 | 1 | 5 | 2.78 | 0.95 | 7 |
All | 2.85 | 1.94 | 1.47 | 6 | 3.96 | 2.17 | 0.94 | 22 |
Bone and visceral metastases | ||||||||
Bone | 3.5 | 2.85 | 2.77 | 3 | 3.9 | 1.4 | 3.5 | 3 |
Adrenal gland | NA | NA | NA | NA | 5.61 | 3.38 | 12.18 | 1 |
All | 3.5 | 2.85 | 2.77 | 3 | 4.76 | 2.39 | 6.43 | 4 |